Cooper J D, Muirhead D C, Taylor J E
BAS Analytics, Warwickshire, UK.
J Pharm Biomed Anal. 1999 Dec;21(4):787-96. doi: 10.1016/s0731-7085(99)00199-5.
The use of the system, automated sequential trace enrichment of dialysates (ASTED), to prepare plasma and saliva prior to high pressure liquid chromatography of eletriptan (HPLC) is described. Chromatographic identification of one metabolite, UK-135,800 was also established. Using this technique the procedure was observed to be specific and linear over the range 0.50-250 ng/ml. The intra-batch imprecision (C.V.) of the method ranged from 0.56 to 5.70% at plasma eletriptan concentrations from 5.00 to 200 ng/ml, and the corresponding inter-batch imprecision ranged from 1.44 to 6.36%. At these plasma analyte concentrations, the overall inaccuracy (% bias) of the procedure ranged from -5.00 to 1.50%. Similar performances were observed for the estimation of eletriptan in saliva using near identical assay conditions. The application of the assay to a pharmacokinetic investigation during a clinical study is presented.
本文描述了使用自动连续透析液痕量富集系统(ASTED)在依立普坦高压液相色谱(HPLC)分析前制备血浆和唾液的方法。还建立了一种代谢物UK-135,800的色谱鉴定方法。使用该技术,观察到该方法在0.50 - 250 ng/ml范围内具有特异性和线性。在血浆依立普坦浓度为5.00至200 ng/ml时,该方法的批内不精密度(变异系数)范围为0.56%至5.70%,相应的批间不精密度范围为1.44%至6.36%。在这些血浆分析物浓度下,该方法的总体误差(偏差百分比)范围为-5.00%至1.50%。在几乎相同的分析条件下,对唾液中依立普坦的测定也观察到了类似的性能。本文还介绍了该分析方法在一项临床研究中的药代动力学研究中的应用。